Certain August 2017 Convertible Debentures of Immune Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 17-JAN-2018. These August 2017 Convertible Debentures will be under lockup for 90 days starting from 19-OCT-2017 to 17-JAN-2018. Details: The our officers, directors and certain of our stockholders have agreed that they will not offer, sell, pledge or otherwise dispose of any shares of common stock or securities convertible into shares of common stock and securities exchangeable or exercisable for shares of common stock for a period of 90 days following the date of the prospectus, without the prior written consent of Maxim Group LLC.